| Adherence to long-term therapies: evidence for action World Health Organization World Health Organization, 2003 | 6828 | 2003 |
| Adherence to long-term therapies: evidence for action E Sabaté World Health Organization, 2003 | 5973 | 2003 |
| Adherence to long-term therapies: evidence for action S De Geest, E Sabaté European Journal of Cardiovascular Nursing 2 (4), 323-323, 2003 | 719 | 2003 |
| Adherence to long-term therapies: evidence for action. PV Burkhart, E Sabaté Journal of Nursing Scholarship 35 (3), 2003 | 560 | 2003 |
| WHO adherence meeting report E Sabate Geneva: World Health Organization, 2001 | 206 | 2001 |
| Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 … D Stark, M Nankivell, E Pujade-Lauraine, G Kristensen, L Elit, M Stockler, ... The lancet oncology 14 (3), 236-243, 2013 | 192 | 2013 |
| The challenge of chronic conditions: WHO responds: the sooner governments act, the better JA Epping-Jordan, R Bengoa, R Kawar, E Sabaté Bmj 323 (7319), 947-948, 2001 | 173 | 2001 |
| Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003 E Sabate apps. who. int/iris/bitstream/handle/10665/42682/9241545992. pdf, 2016 | 148 | 2016 |
| Adherencia a los tratamientos a largo plazo: pruebas para la acción E Sabate Organización Mundial de la Salud (OMS), 2004 | 111 | 2004 |
| Adherence to long-term therapies: policy for action: meeting report, 4-5 June 2001 E Sabaté, World Health Organization World Health Organization, 2001 | 94 | 2001 |
| Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003 E Sabaté WHO/MNC/03.01, 2018 | 66 | 2018 |
| NOAC adherence of patients with atrial fibrillation in the real world: dosing frequency matters? J Hwang, S Han, HJ Bae, SW Jun, SW Choi, CH Lee, IC Kim, YK Cho, ... Thrombosis and haemostasis 120 (02), 306-313, 2020 | 45 | 2020 |
| Adherencia a los tratamientos a largo plazo E Sabaté Génova: organización Mundial de la Salud, 2004 | 45 | 2004 |
| World bank pharmaceuticals R Govindaraj, MR Reich, JC Cohen World Bank, Washington, DC, 2000 | 42 | 2000 |
| Adherence to long-term therapies management: a call for cardiovascular nursing managers and policymakers E Sabaté, S De Geest Progress in cardiovascular nursing 19 (1), 28-29, 2004 | 26 | 2004 |
| Adherencia a los tratamientos a largo plazo: pruebas para la acción World Health Organization Organización Mundial de la Salud, 2004 | 24 | 2004 |
| Depression in young people and the elderly E Sabaté Priority medicines for Europe and the world “A public health approach to …, 2004 | 23 | 2004 |
| Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers S De Castro, E Sabaté Clinical infectious diseases 37 (Supplement_5), S464-S467, 2003 | 19 | 2003 |
| The magnitude of the problem of poor adherence World Health Organization Adherence to Long-Term Therapies: Evidence for Action, 7-10, 2003 | 13 | 2003 |
| Self-management behaviors of patients with type 1 diabetes: comparing two sources of patient-generated data G Karway, MA Grando, K Grimm, D Groat, C Cook, B Thompson Applied Clinical Informatics 11 (01), 070-078, 2020 | 11 | 2020 |
Michael R. ReichProfessor of International Health Policy, Harvard School of Public HealthEmail verificata su harvard.edu